Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Q-linea logo — company profile

Q-linea

Founded 2008 Sweden Sweden 95 employees Biopharma, Biotechnology

General Information

Company Name Q-linea
Founded Year 2008
Location Sweden Sweden +2
Employees 95
Industries Biopharma, Biotechnology
Social

Get notified when Q-linea moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Q-linea

Q-linea is a biotech startup founded in 2008, based in Sweden. The company focuses on developing innovative technology to aid healthcare professionals in improving patient outcomes. Their flagship product, ASTar, is a fully automated instrument for antimicrobial susceptibility testing. It significantly reduces the time to obtain sensitivity profiles from positive blood cultures, providing results in approximately six hours, which is 24 to 40 hours faster than current diagnostics. This rapid turnaround time contributes to the reduction of broad-spectrum antibiotic usage. Additionally, ASTar is CE-IVD certified and US-FDA cleared, ensuring compliance with regulatory standards. Q-linea aims to create sustainable healthcare by providing infectious disease diagnostics for the benefit of patients, physicians, and society. With the potential to revolutionize infectious disease diagnostics, Q-linea presents an intriguing investment opportunity for venture capitalists looking to support disruptive technologies in the biopharma and biotechnology industries.

No funding data available for Q-linea yet.

Get notified when Q-linea raises funding

Q-linea Alternatives & Competitors

Q-linea vs
vantix® DIAGNOSTICS, Inc
vantix® DIAGNOSTICS, Inc United States

Pioneering precise detection in medical, veterinary, and environmental diagnostics since 2010.

Series Unknown
1 employees
Hardware, Health Care
Q-linea vs
Magnolia Diagnostics
Magnolia Diagnostics United States

Get Better Sooner

Seed
13 employees
Health Care
Q-linea vs
HALO Precision Diagnostics
HALO Precision Diagnostics United States

Precision diagnostics for early disease detection.

Series B
180 employees
Enterprise Software, Health Care

FAQ About Q-linea

At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future...
Q-linea was founded in 2008.
Q-linea is headquartered in Sweden.
Q-linea operates in the following industries: Biopharma, Biotechnology.
Q-linea has approximately 95 employees.
Top alternatives and competitors to Q-linea include vantix® DIAGNOSTICS, Inc, Magnolia Diagnostics, HALO Precision Diagnostics, Advanced Diagnostics Healthcare System, Day Zero Diagnostics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Q-linea and vantix® DIAGNOSTICS, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Q-linea and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy